Donald Dwyer Biography and Net Worth

Chief Business Officer of Vivani Medical

Mr. Dwyer is a science-based business leader with over 40 years of experience in the biopharmaceutical industry. Mr. Dwyer serves as Chief Business Officer and corporate secretary of Vivani and served as CBO of Nano Precision Medical (NPM) since 2021 until its acquisition by Vivani in September 2022. Prior to this, Mr. Dwyer was consultant to NPM and an observer to NPM's Board of Directors from 2016-2019. From 1995–2019, Mr. Dwyer held leadership positions at AstraZeneca in business development, US commercial brand management, sales, and drug development. Mr. Dwyer co-led the $2.7B acquisition of ZS Pharma and the $1.2B licensing agreement with Targacept. Mr. Dwyer was also US commercial leader for Toprol-XL (hypertension), Onglyza (diabetes), Seroquel (bipolar disorder) and Abraxane (cancer). At Cephalon (now Teva Pharmaceuticals) Mr. Dwyer was the head of regulatory affairs from 1993–1995 and from 1986–1993 he was with Rhone-Poulenc Rorer (now Sanofi-Aventis).

Mr. Dwyer is a graduate of the University of Central Connecticut and Temple University Fox School of Business (MBA).

What is Donald Dwyer's net worth?: The estimated net worth of Donald Dwyer is at least $77 thousand as of April 1st, 2025. Mr. Dwyer owns 55,000 shares of Vivani Medical stock worth more than $77,000 as of August 28th. This net worth approximation does not reflect any other investments that Mr. Dwyer may own. Learn More about Donald Dwyer's net worth.
How do I contact Donald Dwyer?: The corporate mailing address for Mr. Dwyer and other Vivani Medical executives is 13170 TELFAIR AVE., SYLMAR CA, 91342. Vivani Medical can also be reached via phone at (818) 833-5000 and via email at [email protected]. Learn More on Donald Dwyer's contact information.
Has Donald Dwyer been buying or selling shares of Vivani Medical?: Donald Dwyer has not been actively trading shares of Vivani Medical in the last ninety days. Most recently, on Tuesday, April 1st, Donald Dwyer bought 4,000 shares of Vivani Medical stock. The stock was acquired at an average cost of $1.02 per share, with a total value of $4,080.00. Following the completion of the transaction, the insider now directly owns 55,000 shares of the company's stock, valued at $56,100. Learn More on Donald Dwyer's trading history.
Are insiders buying or selling shares of Vivani Medical?: During the last twelve months, Vivani Medical insiders bought shares 11 times. They purchased a total of 20,411,699 shares worth more than $26,009,104.89. The most recent insider tranaction occured on June, 15th when Director Gregg Williams bought 1,587,301 shares worth more than $1,999,999.26. Insiders at Vivani Medical own 53.3% of the company. Learn More about insider trades at Vivani Medical.
Information on this page was last updated on 6/15/2026.

Donald Dwyer Insider Trading History at Vivani Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2025	Buy	4,000	$1.02	$4,080.00	55,000
2/28/2025	Buy	1,000	$1.11	$1,110.00	51,000
10/3/2024	Buy	500	$1.13	$565.00	50,000
10/1/2024	Buy	1,000	$1.14	$1,140.00	48,500
7/30/2024	Buy	5,000	$1.24	$6,200.00	43,500
11/22/2023	Buy	1,000	$0.96	$960.00	36,500
11/20/2023	Buy	2,500	$0.96	$2,400.00	33,500
9/27/2023	Buy	1,000	$1.01	$1,010.00	31,000
8/31/2023	Buy	7,500	$0.94	$7,050.00	30,000
8/17/2023	Buy	7,500	$1.08	$8,100.00	22,500
6/22/2023	Buy	5,000	$1.24	$6,200.00	15,000
11/17/2022	Buy	5,000	$1.50	$7,500.00	5,000

Donald Dwyer Buying and Selling Activity at Vivani Medical

Vivani Medical Company Overview

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Today's Range

Now: $1.40

$1.40

$1.42

50 Day Range

MA: $1.34

$1.13

$1.60

2 Week Range

Now: $1.40

$0.92

$1.92

Volume

86,719 shs

Average Volume

177,342 shs

Market Capitalization

$126.28 million

P/E Ratio

N/A

Dividend Yield